Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan;28(1):15-16.
doi: 10.1002/lt.26270. Epub 2021 Sep 7.

Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?

Julien Vionnet  1 , Alberto Sánchez-Fueyo
Affiliations
Editorial

Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?

Julien Vionnet et al. Liver Transpl. 2022 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Vionnet J, Sánchez‐Fueyo A. Biomarkers of immune tolerance in liver transplantation. Hum Immunol 2018;79:388–394.
    1. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012;307:283–293.
    1. Benítez C, Londoño M‐C, Miquel R, Manzia T‐M, Abraldes JG, Lozano J‐J, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013;58:1824–1835.
    1. Shaked A, DesMarais MR, Kopetskie H, Feng S, Punch JD, Levitsky J, et al. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation. Am J Transplant 2019;19:1397–1409.
    1. Feng S, Bucuvalas JC, Mazariegos GV, Magee JC, Sanchez‐Fueyo A, Spain KM, et al. Efficacy and safety of immunosuppression withdrawal in pediatric liver transplant recipients: moving toward personalized, anagement. Hepatology 2021;73:1985–2004.